Insider transactions

Gregory M Sullivan

CIK 1610106 · Chief Medical Officer · last filed 2026-02-26

Gregory M Sullivan is a Chief Medical Officer who has filed 23 SEC Form 4 insider transactions across 1 company since 2014. The most recent filing, for TNXP, was dated Feb 26, 2026. Across all open-market trades the lifetime net is +$255.5K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
23
Lifetime Open-Market Net
$255.5K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address
C/O TONIX PHARMACEUTICALS HOLDINGS CORP
509 MADISON AVE., SUITE 306
NEW YORK, NY 10022
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TNXP Chief Medical Officer 0 $8.12 $0 $255.5K 23 2026-02-26

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-02-26 TNXP Grant (A) — $0 EDGAR
2025-02-27 TNXP Mixed −0 -$0 EDGAR
2024-02-29 TNXP Grant (A) — $0 EDGAR
2023-02-24 TNXP Grant (A) — $0 EDGAR
2022-02-17 TNXP Grant (A) — $0 EDGAR
2021-02-25 TNXP Grant (A) +41,322 $21.1K EDGAR
2020-08-19 TNXP Buy (P) +20,000 $20.6K EDGAR
2020-05-06 TNXP Grant (A) — $0 EDGAR
2020-02-27 TNXP Grant (A) — $0 EDGAR
2019-05-08 TNXP Grant (A) — $0 EDGAR
Showing 1–10 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.